Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications

Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications

Survivin (BIRC5) is a tumor-associated antigen (TAA) overexpressed in various tumors but present at low to undetectable levels in normal tissue. Survivin is known to have a high expression in breast cancer (e.g., Ductal Carcinoma in situ (DCIS) and triple negative breast cancer). Previous studies ha...

Full description

Bibliographic Details
Main Authors: Sharon Wright, Scott R. Burkholz, Cathy Zelinsky, Connor Wittman, Richard T. Carback, Paul E. Harris, Tikoes Blankenberg, Charles V. Herst, Reid M. Rubsamen
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:International Journal of Molecular Sciences
Subjects:
breast cancer
immuno-oncology
bioinformatics
artificial intelligence
next-generation sequencing
survivin
Online Access:https://www.mdpi.com/1422-0067/24/14/11827

Similar Items

Similar Items